Natus Medical Story

Natus Medical Incorporated -- USA Stock  

USD 39.2  0.45  1.13%

Macroaxis does not monitor all media channels or aggregates social signals for Natus Medical. But even though we do not provide professional-grade financial sentiment analysis on Natus Medical Incorp, we do publish noise-free headlines that can be used to derive useful patterns or even a trading strategy for Natus Medical. Check also Natus Medical Hype Analysis, Natus Medical Correlation and Natus Medical Performance
Integra LifeSciences To Sell Certain Neurosurgery Assets To Natus Medical
- Integra LifeSciences Holdings Corp. Monday announced a definitive agreement to sell certain neurosurgery assets to Natus Medical Inc. for 47.5 million. Natus expects the acquisition to be immediately accretive to earnings. INTEGRA LIFESCIENCES HOLDINGS CORPORATION Files An 8-K Entry ... - Market Exclusive

Read More...   

Story Momentum

This media report from markets.businessinsider.com distributed on September 11, 2017 was a factor to the next trading day price appreciation.The overall trading delta against the next closing price was 1.82% . The trading delta at closing time when the story was published against the current closing price is 10.22% .

Similar stores for Natus Medical

Kennametal Holder Bronson Point Management Decreased Holding by 314500 Lyon Street Capital Has ...news
Hill Country TimesBeddow Capital Management Has Raised Its Natus Medical Position Winmark Has 2.35 Sentiment San TimesFull coverage
over two weeks ago at http://earlebusinessunion.com 
Tenkan Sen Shows Bearish Movement For Natus Medical Inc
news
Natus Medical Inc moving averages reveal that the Tenkan line of the shares are below the Kijun-Sen line, indicating potential downward momentum building in the bearish chart.
over a month ago at http://berryrecorder.com 
Sale by D Chung of 12642 shares of Natus Medical
news
Filed transaction by Natus Medical Inc officer. General open market or private sale of non-derivative or derivative security
over three months ago at www.macroaxis.com 
Sale by Robert Gunst of 4400 shares of Natus Medical
Macroaxis News
Filed transaction by Natus Medical Inc director. General open market or private sale of non-derivative or derivative security

Did you try this?

Run Watchlist Optimization Now
   

Watchlist Optimization

Optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm
Hide  View All  NextLaunch Watchlist Optimization

Revenue

Revenue Comparative Analysis
  Revenue 
      Natus Medical Comparables 
Natus Medical is currently under evaluation in revenue category among related companies. Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of business and is important item when evaluating financial statements of a company. Revenues from a firm's main business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which given company operates.